Effects of Gender and Apolipoprotein E on Novelty MMN and P3a in Healthy Elderly and Amnestic Mild Cognitive Impairment

about

Effects of Gender and Apolipoprotein E on Novelty MMN and P3a in Healthy Elderly and Amnestic Mild Cognitive Impairment

Item

http://www.wikidata.org/entity/Q58728997

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Effects of Gender and Apolipop ...... stic Mild Cognitive Impairment

@en

Effects of Gender and Apolipop ...... stic Mild Cognitive Impairment

@nl

type

Item

label

Effects of Gender and Apolipop ...... stic Mild Cognitive Impairment

@en

Effects of Gender and Apolipop ...... stic Mild Cognitive Impairment

@nl

prefLabel

Effects of Gender and Apolipop ...... stic Mild Cognitive Impairment

@en

Effects of Gender and Apolipop ...... stic Mild Cognitive Impairment

@nl

P1476

Effects of Gender and Apolipop ...... stic Mild Cognitive Impairment

@en

P2093

Duan Liu

http://www.w3.org/2001/XMLSchema#string

Hao Shu

http://www.w3.org/2001/XMLSchema#string

Jiu Chen

http://www.w3.org/2001/XMLSchema#string

Lihua Gu

http://www.w3.org/2001/XMLSchema#string

Lijuan Gao

http://www.w3.org/2001/XMLSchema#string

Yanna Yan

http://www.w3.org/2001/XMLSchema#string

Zan Wang

http://www.w3.org/2001/XMLSchema#string

Zhijun Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

The mismatch negativity (MMN) in basic research of central auditory processing: a review

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Mild cognitive impairment as a diagnostic entity

Mismatch negativity latency as a biomarker of amnestic mild cognitive impairment in chinese rural elders.

Auditory P3 in antidepressant pharmacotherapy treatment responders, non-responders and controls.

Mismatch negativity (MMN) amplitude as a biomarker of sensory memory deficit in amnestic mild cognitive impairment.

Mild cognitive impairment: an overview.

Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations.

P304

256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNAGI.2018.00256

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30186155

http://www.w3.org/2001/XMLSchema#string

P921

Ageing

P932

6110901

http://www.w3.org/2001/XMLSchema#string